STAT+: Minnesota report shows large hospitals continue to...

What’s Happening

Not gonna lie, Minnesota hospitals and clinics participating in a controversial U.

Drug discount program reaped at least $1. 34 billion in revenue in 2024. (we’re not making this up)

Pharmalot Pharmalot STAT Plus: Up and down the ladder: The latest comings and goings By Ed Silverman Pharmalot Pharmalot STAT Plus: Pharmalittle: Were reading about FDA and a smear campaign, Cigna buying a large pharmacy, and more By Ed Silverman Pharmalot Pharmalot STAT Plus: Justice Department backs AbbVie in its bid to overturn a Colorado law guiding a drug discount program By Ed Silverman Pharmalot Pharmalot STAT Plus: Pharmalittle: Were reading about a puzzling FDA rejection, a Lilly weight loss pill, and more By Ed Silverman Pharmalot Pharmalot STAT Plus: Pharmalittle: Were reading about Trumps drug-price claims, a Novo deal for obesity drugs, and more By Ed Silverman STAT Plus: Jeffrey Epstein’s tissue samples ignited a furor in the Harvard lab of George Church By Megan Molteni STAT Plus: FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad By Lizzy Lawrence and John Wilkerson STAT Plus: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers By Allison DeAngelis STAT Plus: A rare disease drug was approvable, then it wasn’t.

Why This Matters

Inside a surprise rejection By Adam Feuerstein STAT Plus: Brain implants: Whats standing in the way of pivotal trials, FDA approval By O.

Health experts are weighing in on what this means for people.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

Are you here for this or nah?